The absolute configuration of botrylactone, a unique compound with an interesting polyketide lactone skeleton with two oxirane bridges previously isolated from Botrytis cinerea and described as a powerful antibiotic, has been reviewed on the basis of sign of the optical rotation, NOE experiments and NMR method. The isolation of 7-deoxybotrylactone and 5-hydroxy-7-(4-hydroxydec-2(3)-enoyl) botrylactone enables us to characterize an intriguing new family of compounds with this interesting polyketide skeleton. A common biosynthetic origin with botcinin derivatives is proposed.
Introduction
Botrytis cinerea is a well-known pathogen affecting a number of commercial crops, which produces several structurally unique metabolites. Botrytis produces two series of phytotoxic metabolites: a family of characteristic sesquiterpene metabolites with the basic botryane skeleton, principally botrydial and dihydrobotrydial and a family of polyketide lactones. The first isolated polyketide was reported by Cutler in 1993 who called it botcinolide (1), proposing a highly hydroxylated nonanolactone structure. 1 Based on botcinolide structures and in addition to other botcinolide metabolites, we described 2 new metabolites and investigated the biosynthesis of the botcinolide skeleton. 3 In 2005, Nakajima's group reported the isolation of a group of antifungal metabolites, which they designated as botcinins. 4 The absolute configuration of botcinin A (2) was determined through the modified Mosher method. A careful reinvestigation of the spectroscopic data reported for botcinolide analogues allowed them to revise the structures of botcinolide derivatives to botcinic (3) and botcineric (4) acids and their cyclized derivatives, botcinins AeF. 5 Ultimately, the revised structures of this group of natural products were unequivocally determined by total synthesis 6 and a revision comparing the botcinolides with their corresponding botcinin structures has been reported. 7 Recently, a genetically modified strain of B. cinerea, Dbcbot2, which is unable to produce botryanes but significantly overproduces botcinic acid (3) and its derivatives was constructed. 8 The higher production capacities of this strain prompted us to reinvestigate the metabolites produced by it. Additionally, in the course of our investigation on biotransformation with a wild strain of B. cinerea (UCA 992), a new metabolite with a botrylactone skeleton was isolated. This paper focuses on the characterization and biosynthetic route proposal of an intriguing new family of compounds, botrylactones, which could be an intermediate in the biosynthesis to botcinins. Additionally, the absolute configuration of botrylactone (6) and the structure of 2-epihomobotcinolide (5) are revised.
Results and discussion
Botrylactone is a unique C-9 polyhydroxylated lactone described as a powerful antibiotically active compound reported by Welmar et al. 9 Several unsuccessful attempts to isolate this intriguing compound have been made and some of them reported. 10 Recently we isolated it from the B. cinerea cat 2 strain.
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Isolation of botrylactone together with botcinins, 3 and the similarity of their spectroscopic data, led us to believe that they are closely related metabolites. However, comparison of the stereochemistry proposed for botrylactone (6) and that proposed for botcinin A (2) turned out be diametrically opposed. These data, together with the overproducer mutant Dbcbot2, prompted us to conduct a study of 6 focusing on botcinic acid derivatives.
The Botrytis cinerea mutant, Dbcbot2, was cultured on malt agar medium at 24e26 C for 7 days. The fermentation broth, after filtration and extraction was purified following the methodology described in the Experimental section. In addition to botcinin A (2) and B (7), (þ)-botrylactone (11) and 3-acetylbotcineric acid (8), a metabolite whose spectroscopic and physical constants were identical to those described for 2-epihomobotcinolide (5) 3 and a new compound with a botrylactone skeleton, 5-hydroxy-7-(4-hydroxydec-2(3)-enoyl)botrylactone (12) , were isolated.
A careful spectroscopic study of the physical constants of 5 and its comparison with those of botcinin derivatives described in the literature showed that the 1 H NMR and 13 C NMR of 5 were very similar to those of botcinin E (9). 5 The 13 C NMR, including DEPT data, showed that 5 has two more methylenes than 9. The fragment ion assignable to the fatty acyl portion was detected at m/z 169, which is characteristic of a C 10 H 16 O. Thus, 5 differ from 9 in the length of the acyl portion. The key NOE correlations were identical to those of 9 indicating that 5 and 9 share the same relative stereochemistry. Therefore, the structure of 2-epihomobotcinolide (5) should be revised to 10 and renamed as botcinin G. Botrylactone was reported for the first time by Welmar et al. 9 who initially proposed structure 6a based on spectroscopic data. Although they used the term, 'absolute configuration' in the text of the paper, they did not determine the absolute configuration but its relative configuration by X-ray diffraction of its acetate derivative (6b). 9 Later, Redlich et al. synthesized it and revised the originally published structure to 7-OHa-botrylactone (6).
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The optical rotation of natural botrylactone had not been previously reported. Welmar et al. prepared acetyl botrylactone and reported its optical rotation as þ88 (c 1, CHCl 3 ), 9 while Redlich et al.
described it for synthetic botrylactone (6) as L31 (c 0.14, MeOH).
The isolation of a sufficient amount of natural botrylactone from
Dbcbot2 has enabled us to measure its optical rotation determined as þ19 (c 2.6, CHCl 3 ), the opposite sign of that described for the synthetic compound. Acetylation of it led us to a product whose spectroscopic data were identical to those described for natural acetyl botrylactone whose optical rotation proved to be þ73 (c 2.4 mg, CHCl 3 ), coinciding with the sign described by Welmar et al. 9 As a result, it can be inferred that the structure synthesized by Redlich et al. should be the enantiomeric to the natural compound, (À)-botrylactone (6) . In order to confirm this hypothesis we determined the absolute configuration of natural (þ)-botrylactone using the NMR method. (þ)-Botrylactone was treated with R (À) and S (þ)-MPA acid yielding the corresponding R and S-MPA esters 11a and 11b, respectively. Comparison of the chemical shifts in 1 H NMR spectra of the two compounds showed a negative Dd RS value for C 8 eCH 3 and C 9 eCH 3 , (À0.57 and À0.26 ppm, respectively), while the
Dd
RS for H-6 and C 6 eCH 3 were positive (0.11 and 0.47 ppm). Application of the Mosher rule 12 showed a 7R configuration for esterificated products 11a and hence for (þ)-botrylactone (11) . The stereochemistry of the rest of the chiral carbons was confirmed on the basis of NOE data ( Fig. 1) . Irradiation of the H-7 signal of compound 11a produced NOE enhancement of H-5a, C 6 eCH 3 and C 9 eCH 3 , establishing a boat conformation for this tetrahydropyran ring, which was confirmed by irradiation of H-5b that enhanced the signals of H-6, C 6 eMe, C 4 eMe and H-5a. A quasi-boat conformation was established for pentanolide ring on the basis of NOE enhancement of C 2 eMe, C 4 eMe and H-3 observed when H-2 was irradiated. These data coincide with a configuration where H-2, C 4 eMe and C 8 eMe were on the b face and H-3, H-7, C 6 eMe and C 9 eCH 3 were on the a. The absolute stereochemistry of natural botrylactone, (þ)-11, was definitively established as 2R, 3S, 4S, 6S, 7R, 8R, 9R.
Compound 12 was isolated as an oil whose molecular formula was established as C 24 Furthermore, during the course of our biotransformation experiments with B. cinerea UCA 992 13 we found a new compound 13
with an NMR pattern very similar to that of (þ)-botrylactone (11), the principal difference being the absence of the characteristic H-7 signal in its 1 H NMR spectrum and one of the carbon bearing to oxygen and the presence of a signal corresponding to one more methylene in the 13 C NMR spectrum. Therefore, 13 differ from 11 in the absence of the hydroxyl group on C-7. HRMS confirms this showing an ion assignable to C 13 H 22 O 3 [MÀCO] þ at m/z 226.1573.
The botrylactone skeleton was confirmed by the 2D NMR data where correlation in the HMBC experiment between the characteristic quaternary carbon signal (d C 104.8 ppm) and signals corresponding to H-3, H 2 -7 and two methyl singlet groups, which were further correlated with C-8 were observed. The key NOE correlations were identical to those of 11a, indicating that 11 and 13 share the same relative stereochemistry. On the basis of these data the structure of 13 was suggested to be 2R, 3S, 4S, 6S, 8R, 9R-7-dehydroxybotrylactone. The occurrence of botrylactone derivatives and botcinins in the same strain, their structural homology, the resulting absolute configuration of natural botrylactone (11) therefore being identical to that assigned to botcinins by Nakajima 4 except in C-8, seems to indicate that both compounds may be biogenetically related. Incorporation studies with 13 C and 2 H-labelled precursors conducted by our group 3 indicated that 3-O-acetylhomobotcinolide (14) was an acetate derived polyketide whose methyl groups originate from C-methyl methionine. This conclusion is applicable to its revised structure, 8, but an important question, the presence of the methyl group derived from C-methyl methionine on the C-8 carbon atom, the alleged carbon two of the starter-acetate unit, has yet to be resolved.
Conclusions
A plausible explanation for this, which has been previously reported for other natural products, such as aurovertin, 14 is that B.
cinerea biosynthesis involves a C 10 -polyketide, which is methylated at activated methylene groups, followed by the loss of the starteracetate unit through a retro-Claisen type CeC bond cleavage with inversion of configuration at C-8 (Scheme 1).
This hypothesis is in agreement with the common biosynthetic origin of botrylactone (11) 
Microorganism
B. cinerea mutant strain, bcbot2D, was supplied by Dr. Muriel Viaud of the UMR BIOGER, INRA (Versailles, France). The strain was maintained viable on mycelia discs of 0.5 cm diameter submerged in 80% glycerol at À40 C.
B. cinerea (UCA 992) was obtained from grapes from Domecq vineyard, Jerez de la Frontera, Cadiz, Spain. This culture is deposited at the Universidad de Cadiz, Facultad de Ciencias Mycological Herbarium Collection (UCA). 
Culture conditions

Extraction and isolation of metabolites
After 7 days of incubation under fluorescent light, the culture media were filtered, saturated with NaCl, extracted with ethyl acetate (3Â0.5 vol) and washed with water (3Â0.25 vol). The organic extracts were dried over Na 2 SO 4 and concentrated to dryness.
Preliminary fractionation of the extracts was achieved by column chromatography eluting with petroleum ether/ethyl acetate mixtures containing increasing percentages of ethyl acetate (10e100%) to give 10 fractions F1eF10. Final purification of each fraction was carried out by means of semi-preparative or analytical HPLC. Botcinin A (2), botcinin B (2a), botcinin G (10), 3-O-acetylbotcineric acid (8) ; t R around 29 and 35 min, respectively. 
Botcinin G (10
Acetylation of botrylactone
Botrylactone (11, 10 mg) was dissolved in dry pyridine (1 mL, 0.001 mmol) and acetic anhydride (2.4 mL, 24,6 mmol) was added dropwise. The reaction mixture was stirred for 24 h. Then the solvent was removed and the crude reaction product chromatographed to give botrylactone acetate (11c). Colourless oil; [a] D 25 þ73, (c 2.4 mg, CHCl 3 ). 4.6. a-Methoxyphenylacetyl ester of botrylactone A solution of the botrylactone (11, 10 mg, 0.037 mmol) in dry dichloromethane CH 2 Cl 2 (1.5 mL) was treated with DMAP (9.05 mg, 2.0 equiv) and (þ)-(2S)-or (À)-(2R)-2-methoxy-2-phenylacetic acid MPA (13.85 mg, 2.25 equiv). After 15 min stirring at room temperature, EDC (14.91 mg, 2.1 equiv) was added. Stirring was maintained for 24 h. The solvent was stirred under reduced pressure. Residue purification was achieved by flash column chromatography on silica gel (elution with 60:40 hexane/ethyl acetate).
